-
Product Insights
Cystinosis Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Cystinosis Global Clinical Trials Review, H2, 2017" provides an overview of Cystinosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystinosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Cystinosis Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Cystinosis Global Clinical Trials Review, H1, 2019" provides an overview of Cystinosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystinosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Batten Disease Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Batten Disease Global Clinical Trials Review, H2, 2018" provides an overview of Batten Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Batten Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cystinosis Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Cystinosis Global Clinical Trials Review, H2, 2018" provides an overview of Cystinosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cystinosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Global Military Aviation MRO Market 2017-2027
Air platforms have always played critical roles for military forces worldwide both during wars as well as other operations. Advanced aircrafts and rotorcrafts have witnessed continual surge in demand by military forces over the past decades. Owing to the extensive utilization of aircrafts in war situations in Iraq, Afghanistan, Serbia, and Libya has resulted in rapid aging and wearing out of the military aircraft fleet of the major defense forces. As these wars are gradually coming to an end, the...
-
Sector Analysis
OpportunityAnalyzer: Cystic Fibrosis – Opportunity Analysis and Forecasts to 2025
Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which codes for the CFTR protein. As a multisystem condition, CF patients show great heterogeneity in presenting clinical symptoms. CF mainly affects the respiratory and gastrointestinal tracts. Three classes of drugs have been used to for treatment in CF patients: inhaled antibiotics for bacterial and fungal respiratory infections, mucolytic drugs for mucociliary clearance of the airways, and pancreatic enzyme replacement...
-
Sector Analysis
OpportunityAnalyzer: Huntington’s Disease – Opportunity Analysis and Forecast to 2024
HD is a rare, autosomal-dominant, neurodegenerative disorder, characterized by impaired motor control, cognitive dysfunction, behavioral changes, and mood disorders. Approved treatments for HD across the 7MM are extremely limited, consisting of only two symptomatic treatments, tetrabenazine and tiapride, which are both approved for the treatment of HD-associated chorea. Other treatment options contributing to the HD market are off-label symptomatic drugs, many of which are widely genericized throughout the 7MM. Four late-stage pipeline drugs, two symptomatic treatments (SD-809 and pridopidine) and...
-
Product Insights
Batten Disease Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Batten Disease Global Clinical Trials Review, H2, 2016" provides an overview of Batten Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Batten Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H2, 2016" provides an overview of Cognitive Impairment Associated With Schizophrenia (CIAS) clinical trials scenario. This report provides top line data relating to the clinical trials on Cognitive Impairment Associated With Schizophrenia (CIAS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...